INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 5 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $305,000 | -8.7% | 90 | -14.3% | 0.01% | -8.3% |
| Q4 2020 | $334,000 | +24.2% | 105 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $269,000 | -94.8% | 105 | -93.0% | 0.02% | -96.4% |
| Q4 2019 | $5,165,000 | +819.0% | 1,505 | +100.1% | 0.45% | +763.5% |
| Q3 2019 | $562,000 | -77.0% | 752 | -60.1% | 0.05% | -76.6% |
| Q2 2019 | $2,445,000 | – | 1,884 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 50,400 | $2,018,000 | 0.03% |
| SIMPLEX TRADING, LLC | 281 | $170,000 | 0.01% |
| Citadel Advisors | 20,300 | $813,000 | 0.00% |